Pros | ![]() 3Y returns in the top 25% of the category. ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | 5/8 | 3/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 12 Years | 7 Years | ||
Fund Size | 1119 Cr | 6162 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹5000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 1.3% | 1.04% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 43 | 39 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (9.84%) Cipla Ltd (5.43%) Ajanta Pharma Ltd (4.8%) Lupin Ltd (4.29%) Procter & Gamble Health Ltd (4.13%) | Sun Pharmaceuticals Industries Ltd (11.69%) Dr Reddy's Laboratories Ltd (8.85%) Divi's Laboratories Ltd (8.13%) Cipla Ltd (7.54%) Aurobindo Pharma Ltd (5.71%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (98.94%) Basic Materials (1.06%) | Health (96.53%) Basic Materials (2.35%) Financial Services (1.11%) | ||
Equity % | 97.66% | 95.89% | ||
Debt % | - | - | ||
P/E | 37.75 | 31.02 | ||
P/B | 5.77 | 4.22 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 1.89% | 2.79% | ||
3-Month Return | 4.31% | 3.21% | ||
6-Month Return | 16.3% | 17.02% | ||
1-Year Return | 3.31% | 4.29% | ||
3-Year Return | 26.92% | 29.51% | ||
5-Year Return | 20.53% | 22.91% |
Sharpe | 1.15 | 1.31 | ||
Alpha | 2.02 | 4.41 | ||
Beta | 0.95 | 0.94 | ||
Standard Deviation | 15.67 | 15.52 | ||
Information Ratio | 0.5 | 1.42 |
Description | UTI Healthcare Fund-Growth Option- Direct is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Kamal Gada | Dharmesh Kakkad,Sharmila D’mello |